Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ortho-hydroxybenzoic acid or derivative doai
Patent
1997-01-08
1998-06-09
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ortho-hydroxybenzoic acid or derivative doai
424449, 514947, A61K 3160, A61K 970
Patent
active
057634254
ABSTRACT:
A method is disclosed for inducing thromboxane suppression in a mammalian subject by percutaneously administering a pharmaceutical composition containing aspirin. Articles useful for practicing the therapeutic methods of the invention are also disclosed.
REFERENCES:
patent: 3598122 (1971-08-01), Zaffereal
patent: 4012508 (1977-03-01), Burton
patent: 4219548 (1980-08-01), Reller
patent: 4228162 (1980-10-01), Luzzi et al.
patent: 4286592 (1981-09-01), Chandrasekaran
patent: 4460368 (1984-07-01), Allison et al.
patent: 4476115 (1984-10-01), Reed
patent: 4640689 (1987-02-01), Sibalis
patent: 4654209 (1987-03-01), Leslie et al.
patent: 4665063 (1987-05-01), Bar-Shalom
patent: 4810699 (1989-03-01), Sabatucci et al.
patent: 4948588 (1990-08-01), Kamiya et al.
patent: 4954487 (1990-09-01), Cooper et al.
patent: 4970081 (1990-11-01), Frisbee
patent: 4975269 (1990-12-01), Chavkin et al.
patent: 5093133 (1992-03-01), Wisniewski et al.
patent: 5120716 (1992-06-01), Miyazawa et al.
patent: 5223267 (1993-06-01), Nichols
patent: 5240917 (1993-08-01), Keimowitz et al.
patent: 5254346 (1993-10-01), Tucker et al.
Chem Abst. 98 (1983)--46600x, Bertele et al.
Chem Abst. 108 (1988)--180111s, Arai.
Chem Abst. 110 (1989)--141529f, McKie et al.
Chem Abst. 111 (1989)--89965Z, Danesh et al.
Chest, vol. 95, No. 2, Feb. 1989, J. Hirsh et al.: Aspirin and other platelet active drugs--Relationship among dose, effectiveness, and side effects, pp. 12S-18S.
Japanese Pharmacology & Therapeutics, Yakuri to Chiryo, vol. 16, No. 1, Jan. 1988, S.-I. Naito et al.: Percutaneous absorption of salicylic acid derivatives, pp. 17-25.
J.E.F. Reynolds et al.: Martindale the Extra Pharmacopoeia, 29.sup.th Ed., 1989, pp. 3-8, The Pharmaceutical Press, London GB.
The Journal of Burn Care & Rehabilitation, vol. 6, No. 6, Nov./Dec. 1985, J.P. Heggers et al.: Thromboxane inhibitors for the prevention of progressive dermal ischemia due to the thermal injury, pp. 466-468.
The Journal of Clinical Investigation, vol. 69, No. 6, Jun. 1982, P. Patrignani et al.: Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects, pp. 1366-1372.
New England Journal of Medicine, vol. 325, 1991, Thun et al.: Aspirin Use and Reduced Risk of Fatal Colon Cancer, pp. 1593-1596.
Van Moorleghem G L, Derwent WPI, Derwent Publications, Ltd., Week 7647, WPI Acc No: 76-87300X (Abstract of French Patent Application No. 2,297,612, Sep. 17, 1976).
Teisan Seiyaku, Derwent WPI, Derwent Publications, Ltd., Week 8636, WPI Acc No: 86-236772 (Abstract of Japanese Patent Application No. 61-167615, Jul. 29, 1986).
Teikoku Seiyaku, Derwent WPI, Derwent Publications, Ltd., Week 8939, WPI Acc No: 89-280859 (Abstract of Japanese Patent Application No. 1-203336, Aug. 16, 1989).
Nikko Chemicals, Derwent WPI, Derwent Publications, Ltd., Week 8945, WPI Acc No: 89-327620 (Abstract of Japanese Patent Application No. 1-242521, Sep. 27, 1989).
Kyowa Hakko Kogyo, Derwent WPI, Derwent Publications, Ltd., Week 9125, WPI Acc No: 91-183201 (Abstract of Japanese Patent Application No. 3-112926, May 14, 1991).
Fitzgerald Desmond J.
Keimowitz Rudolph M.
Gundersen Clinic, Ltd.
Jarvis William R. A.
LandOfFree
Suppression of thromboxane levels by percutaneous administration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suppression of thromboxane levels by percutaneous administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of thromboxane levels by percutaneous administration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2199245